KRAS and neoplasm: Additionally, gene amplifications of KRAS (32%), BRAF(30%), and EGFR (23%) are common to human BBCs [3] and BBC cell lines and tumor models have been shown to exhibit an oncogenic Ras-like gene expression signature [10].